Overview

NWP09 in Children With Attention Deficit Hyperactivity Disorder (ADHD)

Status:
Completed
Trial end date:
2012-10-01
Target enrollment:
Participant gender:
Summary
The safety and efficacy of a chewable formulation of extended-release methylphenidate will be studied in children with ADHD
Phase:
Phase 3
Details
Lead Sponsor:
Pfizer
Treatments:
Methylphenidate